Innovative Diagnostic Technology Dune Medical Devices specializes in real-time cancer detection and tissue characterization technology, offering surgeons advanced diagnostic tools such as the MarginProbe and Smart Biopsy. This positions the company well for sales opportunities in hospital settings, particularly in oncology and surgical departments seeking cutting-edge diagnostic solutions.

Recent Product Expansions The company has launched multiple innovative products including the reposable MarginProbe and the Smart Biopsy device, demonstrating ongoing product development and strategic expansion. These new offerings create avenues for sales in surgical centers and medical facilities looking to adopt minimally invasive, real-time diagnostic equipment.

Strategic Asset Sale In 2020, Dune Medical sold its assets to Dilon Diagnostics, which indicates a potential shift in company strategy or partnership opportunities. Engaging with Dilon could open joint sales channels or licensing deals for current and future technologies, enhancing market reach.

Focus on RF Spectroscopy The company has invested in expanding its RF platform for smart biopsies and has appointed leadership to advance this technology. This focused expertise suggests opportunities to target hospitals, research institutions, and clinics investing in RF-based diagnostic devices for diverse clinical applications.

Market Position & Revenue Range With a revenue range of 1 to 10 million and a small to mid-sized team, Dune Medical presents a high-growth, innovative company eager to expand its market presence. There is a notable opportunity for strategic partnerships, distribution channels, and sales collaborations to accelerate growth in the medical equipment industry.